Alteration of Blood Circulation in the Upper Limb Before and After Surgery for Breast Cancer Associated with Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy
Restricted accessResearch articleFirst published online December, 2017
Alteration of Blood Circulation in the Upper Limb Before and After Surgery for Breast Cancer Associated with Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy
This aim of this study was to assess and compare arterial and venous circulation in women with axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB) before and after breast cancer surgery.
Methods and Results:
Fifty-two women took part in the study, divided into three groups: those undergoing ALND at levels I, II, and III (ALNDG), with mean age of 56.29 ± 10.85 years old; those undergoing sentinel lymph node biopsy (SLNBG), with mean age of 57.7 ± 7.07 years old; and controls without diagnosis of breast cancer (CG), with mean age of 53.92 ± 8.85 years old. Maximum venous and arterial flow velocities in upper limbs were assessed before and after surgical treatment for breast cancer by means of Doppler ultrasonography (Nicolet Vascular Versalab SE®). Data normality was assessed by using the Shapiro–Wilk's test, with normally distributed variables being analyzed with analysis of variance (ANOVA) and post hoc Tukey's test or t-test. For variables with non-normal distribution, Kruskal–Wallis' test and post hoc Dunn's test were used at p < 0.05. There was significant difference in the maximum blood flow velocities, both venous (ALNDG) and arterial (SLNBG).
Conclusion:
The results suggest that ALND and SLNB can interfere with the upper limp blood circulation.
Get full access to this article
View all access options for this article.
References
1.
RahibL, SmithBD, AizenbergR, RosenzweigAB, FleshmanJM, MatrisianLM. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 2014; 74:2913–2921.
2.
FrancisSR, FrandsenJ, KokenyKE, GaffneyDK, PoppeMM. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers. Breast, 2017; 9:156–161.
3.
MericF, BuchholzTA, MirzaNQ, et al.Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol, 2002; 9:543–549.
4.
McLaughlinSA, WrightMJ, MorrisKT, et al.Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements. J Clin Oncol, 2008; 26:5213–5219.
5.
Van RijkMC, NiewegOE, RutgersEJT, et al.Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer pacients axillary lymph node dissection. Ann Surg Oncol, 2006; 13:475–479.
6.
LymanGH, GiulianoAE, SomerfieldMR, et al.American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol, 2005; 23:7703–7720.
7.
WilkeLG, McCallLM, PostherKE, et al.Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol, 2006; 13:491–500.
8.
BosompraK, AshikagaT, O'BrienPJ, NelsonL, SkellyJ. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: A disablement process model perspective. Breast J, 2002; 8:338–348.
9.
MatheusCN, GuirroECO. Change in blood flow velocity demonstrated by Doppler ultrasound in upper limb after axillary dissection surgery for the treatment of breast cancer. Breast Cancer Res Treat, 2011; 127:697–704.
10.
StantonAW, ModiS, Bennett BrittonTM, et al.Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat, 2009; 117:549–557.
11.
YildirimE, SoydincP, YildirimN, BerberogluU, YukselE. Role of increased arterial inflow in arm edema after modified radical mastectomy. J Exp Clin Cancer Res, 2000; 19:427–430.
12.
MontgomeryLD, DietrichMS, ArmerJM, StewartBR, RidnerSH. Segmental blood flow and hemodynamic state of lymphedematous and non lymphedematous arms. Lymphat Res Biol, 2011; 9:31–42.
13.
HallalPC, VictoraCG. Reliability and validity of the International Physical Activity Questionnaire (IPAQ). Med Sci Sports Exerc, 2004; 36:556.
14.
DavidS, StanleyB, ChrisD, WladyslawG, AlexanderK, JamesL. MR-guided focused ultrasound surgery, present and future. Med Phys, 2013; 40:080901.
15.
WangZ, BaiJ, LiF, DuY, WenS, HuK, XuG, MaP, YinN, ChenW, WuF, FengR. Study of a “biological focal region” of high-intensity focused ultrasound. Ultrasound Med Biol, 2003; 29:749–754.
16.
WuF, WangZ, ChenW, ZouJ, BaiJ, ZhuH, LiK, XieF, JinC, SuH, GaoG. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: Early chinese clinical experience. Ultrasound Med Biol, 2004; 30:245–260.
SanderAP, HajerNM, HemenwayK, MillerAC. Upper-extremity volume measurements in women with lymphedema: A comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther, 2002; 82:1201–1212.
19.
AndersenL, HøjrisI, ErlandsenM, AndersenJ. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage. Acta Oncol, 2000; 39:399–405.
20.
ChangST, ChenCL, ChuCM, et al.Ankle-arm index is a useful test for clinical practice in outpatients with suspected coronary artery disease. Circ J, 2006; 70:686–690.
21.
NicolaïSPA, KruidenierLM, RouwetEV. Pocket Doppler and vascular laboratory equipment yield comparable results for ankle brachial index measurement. BMC Cardiovasc Disord, 2008; 8:26–30.
22.
NorgrenL, HiattWR, DormandyJA, NehlerMR, HarrisKA, FowkesFGR. On Behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg, 2007; 33:S1–S70.
23.
Cunha-FilhoITD, PereiraDAG, CarvalhoAMB, GarciaJP, MortimerLM, BurniIC. Correlation between ankle-arm index before and after progressive bidirectional displacement test. J Vasc Bras, 2007; 6:332–338.
24.
NimuraY, MatsuoH, HayashiT, KitabatakeA, MochizukiS. Studies on arterial flow patterns instantaneous velocity spectrums and their phasic changes with directional ultrasonic Doppler technique. Br Heart J, 1974; 36:899–907.
25.
KohKK, CardilloC, BuiMN, et al.Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation, 1999; 99:354–360.
26.
VerbelenH, GebruersN, EeckhoutFM, VerlindenK, TjalmaW. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: A systematic review. Breast Cancer Res Treat, 2014; 144:21–31.
27.
VignesS, PorcherR, ArraultM, DupuyA. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat, 2007; 101:101–190.
28.
JammalloLS, MillerCL, SingerM, et al.Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat, 2013; 142:59–67.
29.
GuarneriV, PiacentiniF, FicarraG, et al.A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. Ann Oncol, 2009; 20:1193–1198.
30.
UgurS, Arıcı C, Yaprak M, et al. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol, 2013; 11:72–75.
31.
StapletonPA. Obesity and vascular dysfunction. Pathophysiology, 2008; 15:79–89.
32.
SoranA, D'AngeloG, BegovicM, et al.Breast cancer-related lymphedema what are the significant predictors and how they affect the severity of lymphedema?. Breast J, 2006; 12:536–543.
33.
GärtnerR, JensenMB, KronborgL, EwertzM, KehletH, KromanN. Self-reported arm-lymphedema and functional impairment after breast cancer treatment-a nationwide study of prevalence and associated factors. Breast, 2010; 19:506–515.
34.
RezendeLF, PedrasFV, RamosCD, GurgelMS. Evaluation of lymphatic compensation by lymphoscintigraphy in the postoperative period of breast cancer surgery with axillary dissection. Tumori, 2011; 97:309–315.
35.
BlumKS, ProulxST, LucianiP, LerouxJC, DetmarM. Dynamics of lymphatic regeneration and flow patterns after lymph node dissection. Breast Cancer Res Treat, 2013; 139:81–86.
36.
EdwardsJM, KinmonthJB. Lymphovenous shunts in man. Br Med J, 1969; 4:579–586.
37.
Aboul-EneinA, EshmawyI, ArafaS, AbboudA. The role of lymphovenous communication in the development of post mastectomy lymphedema. Surgery, 1984; 95:562.
38.
CelebiogluF, PerbeckL, FrisellJ, GröndalE, SvenssonL, DanielssonR. Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery. Acta Radiol, 2007; 48:488–495.
39.
HopeJC, HowardCJ, PrenticeH, CharlestonB. Isolation and purification of afferent lymph dendritic cells that drain the skin of cattle. Nat Protoc, 2006; 1:982–987.
40.
StampGF, PetersAM. Peripheral lymphovenous communication in lymphoedema. Nucl Med Commun, 2012; 33:701–707.
41.
ValinoteSPA, Freitas-JuniorR, MartinsKA, PereiraAC, PereiraCE, MartinsE. Venous and lymphatic changes in women with lymphedema after axillary lymphadenectomy in the treatment of breast cancer. Rev Bras Ginecol Obstet, 2013; 35:171–177.
42.
PainSJ, VowlerS, PurushothamAD. Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. Br J Surg, 2005; 92:311–315.
43.
BurnandKM, GlassDM, MortimerPS, PetersAM. Lymphatic dysfunction in the apparently clinically normal contralateral limbs of patients with unilateral lower limb swelling. Clin Nucl Med, 2012; 37:9–13.
